Pycnogenol for the Treatment of Lymphedema

Completed · Phase 2 · Has a placebo group

Conditions studied: Lymphedema

In brief

The objectives of this study are to evaluate the effectiveness of Pycnogenol (French maritime pine bark extract) for arm lymphedema in women following treatment for breast cancer, to evaluate the accuracy and sensitivity of bioelectric impedence as a measurement of lymphedema of the arm, and to validate the proposed arm lymphedema quality-of-life questionnaire.

Key facts

Study ID

NCT00214032

Run by

University of Wisconsin, Madison

People needed

2

Starts

2002-05-01

Expected to finish

2007-01-01

Last updated by the study team

2015-10-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• > 6 months from last surgical and/or radiation treatment to the affected axilla
• Unilateral lymphedema of the upper extremity

You may not qualify if…

• May not be receiving or be scheduled to receive cytotoxic or radiation chemotherapy treatment while on this study

Where it is running

• University of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.